COMMUNIQUÉS West-GlobeNewswire

Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
20/05/2026
SUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026
PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
20/05/2026
Virtual webinar to be held on Wednesday, May 27 at 11:00 AM ET LA JOLLA, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Equillium , Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe [...]
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
20/05/2026
State-Funded Firefighter Cancer Screening Programs Expected to Drive Meaningful Revenue Growth Beginning in Q2 2026 $5.0 Million Private Placement Strengthens Cash Position to $4.2 Million as of March 31, 2026 Recent [...]
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
20/05/2026
Year-over-year revenue increased 70%, reflecting contribution from Vivos’ acquisition of The Sleep Center of Nevada Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May 20, 2026 (GLOBE NEWSWIRE [...]
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference
20/05/2026
CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & Paws Conference [...]
Cytokinetics to Hold Annual Meeting of Stockholders
20/05/2026
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 27, 2026 at 10:00 AM Pacific [...]
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
20/05/2026
Perform. Repair. Repeat. — A stimulant-free, dual-phase platform built on the principle that cognitive excellence depends as much on what the brain does overnight as on what it achieves during the day. LAS VEGAS, May 20 [...]
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
20/05/2026
MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026
PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
Informations sur le nombre total de droits de vote et d'actions
20/05/2026
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 20 mai 2026, 22h30 CET / 16h30 ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative [...]
Strongest Phentermine Alternatives 2026: What OTC Options Are Commonly Compared to Phentermine? PhenQ Formulation Assessment Using the SCALE-9 Evaluation Model
20/05/2026
PhenQ Editorial Report: OTC appetite suppressants, natural weight loss pills, prescription vs OTC standards, and a 9-point consumer verification framework for evaluating real-world effectiveness. New York City, NY, May [...]
Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
20/05/2026
Conference call and webcast to discuss results to be held on June 22, 2026 at 8 a.m. ET IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/05/2026
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Johns Hopkins Health Plans Awards $60,000 to Maryland and Virginia Organizations
20/05/2026
Corporate Giving Program Supports Nonprofits Addressing Food Insecurity, Healthy Aging and Child Advocacy HANOVER, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans has announced new recipients of its [...]
Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026
20/05/2026
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Nanobiotix annonce le lancement d’une offre globale
21/05/2026
Paris, France ; Cambridge, Massachusetts (USA), 20 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – « Nanobiotix » ou la « Société »), une société de biotechnologie au stade clinique et en phase [...]
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
BOSTON and SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
20/05/2026
MIAMI, May 20, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today [...]

Pages